YSOPIA Bioscience secures €1.55M in non-dilutive funding from Bpifrance and the European Regional...
Nov 17, 2020
more +LNC Therapeutics becomes YSOPIA Bioscience marking its transition to a clinical stage company
Sep 29, 2020
more +LNC Therapeutics Receives FDA Investigational New Drug Approval to Initiate a Phase 1 Clinical Trial...
Sep 14, 2020
more +LNC Therapeutics Receives FDA Investigational New Drug Approval to Initiate a Phase 1 Clinical Trial...
Sep 8, 2020
more +Discovering the Therapeutic Potential of Keystone Bacteria in Treating Chronic Diseases
Apr 22, 2020
more +